BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 8622883)

  • 41. Cellular targets for activation by c-Myc include the DNA metabolism enzyme thymidine kinase.
    Pusch O; Soucek T; Hengstschläger-Ottnad E; Bernaschek G; Hengstschläger M
    DNA Cell Biol; 1997 Jun; 16(6):737-47. PubMed ID: 9212167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Melanin accumulation accelerates melanocyte senescence by a mechanism involving p16INK4a/CDK4/pRB and E2F1.
    Bandyopadhyay D; Medrano EE
    Ann N Y Acad Sci; 2000 Jun; 908():71-84. PubMed ID: 10911949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.
    Kim YJ; Jung JK; Lee SY; Jang KL
    Cancer Lett; 2010 Feb; 288(2):226-35. PubMed ID: 19656618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcriptional repression and activation in the same cell type of the human c-MYC promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen.
    Batsché E; Lipp M; Cremisi C
    Oncogene; 1994 Aug; 9(8):2235-43. PubMed ID: 8036009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An E2F-dependent late-serum-response promoter in a gene that controls glycolysis.
    Darville MI; Antoine IV; Mertens-Strijthagen JR; Dupriez VJ; Rousseau GG
    Oncogene; 1995 Oct; 11(8):1509-17. PubMed ID: 7478575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of the cyclin-dependent kinase inhibitor p16 during the ongoing cell cycle.
    Soucek T; Pusch O; Hengstschläger-Ottnad E; Wawra E; Bernaschek G; Hengstschläger M
    FEBS Lett; 1995 Oct; 373(2):164-9. PubMed ID: 7589458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway.
    Tashiro E; Maruki H; Minato Y; Doki Y; Weinstein IB; Imoto M
    Cancer Res; 2003 Jan; 63(2):424-31. PubMed ID: 12543798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
    Dbaibo GS; Wolff RA; Obeid LM; Hannun YA
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation.
    Lois AF; Cooper LT; Geng Y; Nobori T; Carson D
    Cancer Res; 1995 Sep; 55(18):4010-3. PubMed ID: 7664273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential regulation of E2F and Sp1-mediated transcription by G1 cyclins.
    Shao Z; Robbins PD
    Oncogene; 1995 Jan; 10(2):221-8. PubMed ID: 7838522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence.
    Tsugu A; Sakai K; Dirks PB; Jung S; Weksberg R; Fei YL; Mondal S; Ivanchuk S; Ackerley C; Hamel PA; Rutka JT
    Am J Pathol; 2000 Sep; 157(3):919-32. PubMed ID: 10980131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. E2F-1 and a cyclin-like DNA repair enzyme, uracil-DNA glycosylase, provide evidence for an autoregulatory mechanism for transcription.
    Walsh MJ; Shue G; Spidoni K; Kapoor A
    J Biol Chem; 1995 Mar; 270(10):5289-98. PubMed ID: 7534293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression.
    Ausserlechner MJ; Obexer P; Geley S; Kofler R
    Leukemia; 2005 Jun; 19(6):1051-7. PubMed ID: 15800668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest.
    Knudsen KE; Fribourg AF; Strobeck MW; Blanchard JM; Knudsen ES
    J Biol Chem; 1999 Sep; 274(39):27632-41. PubMed ID: 10488103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptional regulation. A closer look at E2F.
    Nevins JR
    Nature; 1992 Jul; 358(6385):375-6. PubMed ID: 1641018
    [No Abstract]   [Full Text] [Related]  

  • 56. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition.
    Koh J; Enders GH; Dynlacht BD; Harlow E
    Nature; 1995 Jun; 375(6531):506-10. PubMed ID: 7777061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A common regulation of genes encoding enzymes of the deoxynucleotide metabolism is lost after neoplastic transformation.
    Hengstschläger M; Mudrak I; Wintersberger E; Wawra E
    Cell Growth Differ; 1994 Dec; 5(12):1389-94. PubMed ID: 7696188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implication of transcription factor E2F in regulation of DNA replication.
    Ohtani K
    Front Biosci; 1999 Dec; 4():D793-804. PubMed ID: 10577392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells.
    Christoffersen J; Smeland EB; Stokke T; Taskén K; Andersson KB; Blomhoff HK
    Cancer Res; 1994 Apr; 54(8):2245-50. PubMed ID: 8174134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antileukemic effect of interferon-alpha is mediated through down-modulation of E2F activity.
    Furukawa Y; Iwase S
    Leukemia; 1997 Apr; 11 Suppl 3():446-8. PubMed ID: 9209420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.